Works matching DE "BRINZOLAMIDE"

Results: 57

The effect of a brinzolamide/brimonidine fixed combination on optic nerve head blood flow in rabbits.

Published in:

PLoS ONE, 2023, v. 18, n. 12, p. 1, doi. 10.1371/journal.pone.0295122

By:

Takahashi, Nana;
Sato, Kota;
Kiyota, Naoki;
Yamazaki, Mai;
Kunikane, Eriko;
Nakazawa, Toru

Publication type:

Article

Development of RP-HPLC Method for Simultaneous Determination of Brimonidine Tartrate and Brinzolamide by QbD Approach and Its Validation.

Published in:

Eurasian Journal of Analytical Chemistry, 2016, v. 11, n. 2, p. 63, doi. 10.12973/ejac.2016.122a

By:

Agrawal, Varsha P.;
Desai, Sonal S.;
Jani, Girish K.

Publication type:

Article

Periocular allergic contact dermatitis caused by brinzolamide.

Published in:

Contact Dermatitis (01051873), 2021, v. 84, n. 4, p. 274, doi. 10.1111/cod.13730

By:

Navarro‐Triviño, Francisco J.;
Ruiz‐Villaverde, Ricardo

Publication type:

Article

The Efficacy, Safety, and Satisfaction Associated with Switching from Brinzolamide or Brimonidine to Brinzolamide/Brimonidine in Open-Angle Glaucoma Patients.

Published in:

Journal of Personalized Medicine, 2022, v. 12, n. 12, p. 2057, doi. 10.3390/jpm12122057

By:

Onoe, Hiromitsu;
Hirooka, Kazuyuki;
Nagayama, Mikio;
Mochizuki, Hideki;
Hirota, Atsushi;
Suzuki, Katsuyoshi;
Sagara, Takeshi;
Kiuchi, Yoshiaki

Publication type:

Article

Brinzolamide/Brimonidine Fixed Combination: Simplifying Glaucoma Treatment Regimens.

Published in:

Ophthalmology & Therapy, 2018, v. 7, n. 2, p. 397, doi. 10.1007/s40123-018-0150-x

By:

Moosavi, Reza;
Ansari, Ejaz

Publication type:

Article

Design, development, and characterization of brinzolamide and brimonidine tartrate nanoemulsion for ophthalmic drug delivery.

Published in:

Thai Journal of Pharmaceutical Sciences, 2022, v. 46, n. 4, p. 413

By:

Choradiya, Bhavin R.;
Patil, Sanjay B.

Publication type:

Article

Improvement of corneal epithelial damage after switching from the concomitant use of brinzolamide and brimonidine to a brinzolamide/brimonidine fixed-dose combination.

Published in:

Japanese Journal of Ophthalmology, 2024, v. 68, n. 5, p. 556, doi. 10.1007/s10384-024-01088-w

By:

Maruyama, Yuko;
Ikeda, Yoko;
Yoshii, Kengo;
Mori, Kazuhiko;
Ueno, Morio;
Kinoshita, Shigeru;
Sotozono, Chie

Publication type:

Article

Intraocular pressure-lowering effects and safety of brimonidine/brinzolamide fixed combination after switching from other medications.

Published in:

Japanese Journal of Ophthalmology, 2022, v. 66, n. 5, p. 440, doi. 10.1007/s10384-022-00930-3

By:

Inoue, Kenji;
Kunimatsu-Sanuki, Shiho;
Ishida, Kyoko;
Tomita, Goji

Publication type:

Article

Nanoliposome-Encapsulated Brinzolamide-hydropropyl-β-cyclodextrin Inclusion Complex: A Potential Therapeutic Ocular Drug-Delivery System.

Published in:

Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2018.00091

By:

Wang, Fazhan;
Bao, Xingting;
Fang, Aiping;
Li, Huili;
Zhou, Yang;
Liu, Yongmei;
Jiang, Chunling;
Wu, Jinhui;
Song, Xiangrong

Publication type:

Article

Validation and Experimental Design Assisted Robustness Testing of RPLC Method for the Simultaneous Analysis of Brinzolamide and Brimonidine Tartrate in an Ophthalmic Dosage Form.

Published in:

Indian Journal of Pharmaceutical Sciences, 2016, v. 78, n. 5, p. 631, doi. 10.4172/pharmaceutical-sciences.1000162

By:

CHRISTIAN, J. R.;
PATEL, KALPANA;
GANDHI, T. R.

Publication type:

Article

Comparative Analyses of Efficacy and Safety of Fixed Versus the Free Equivalent Combination of 1% Brinzolamide and 0.5% Timolol in Glaucoma Patients: A Prospective Observational Study.

Published in:

International Journal of Pharmaceutical Research (09752366), 2021, v. 13, n. 2, p. 1104, doi. 10.31838/ijpr/2021.13.02.188

By:

AZMI, TANVI;
AGRAWAL, POOJA;
KUSHWAHA, VIRENDRA;
MOHAN, SHALINI;
KUMAR, AMIT;
SHARMA, HIMANSHU

Publication type:

Article

Stability-Indicating Rp-Hplc Method Development And Validation For Brimonidine Tartrate In Bulk And Ophthalmic Suspension.

Published in:

International Journal of Pharmaceutical Research (09752366), 2020, v. 12, n. 3, p. 3964, doi. 10.31838/ijpr/2020.12.03.520

By:

DIGGE, VAIJINATH G.;
PATIL, S. S.;
PANCHAL, C. V.

Publication type:

Article

BRINZOLAMIDE-2-HYDROXYPROPYL BETA CYCLODEXTRIN COMPLEX LOADED CHITOSAN NANOGEL FOR OCULAR DRUG DELIVERY.

Published in:

International Journal of Pharmaceutical Research (09752366), 2019, v. 11, n. 2, p. 6, doi. 10.31838/ijpr/2019.11.02.002

By:

PILLAI, DHANAJA VIJAYAN;
MANGALATHILLUM, SABITHA;
GUPTA, SWATI

Publication type:

Article

Efficacy of brinzolamide in the initial management of acute primary angle closure: A randomized controlled trial.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 6, p. 792, doi. 10.1111/jcpt.13609

By:

Chen, Guang;
Peng, Xinming;
Li, Jun;
Chen, Peng;
Wang, Jing

Publication type:

Article

Toxicity and Physiological Actions of Carbonic Anhydrase Inhibitors to Aedes aegypti and Drosophila melanogaster.

Published in:

Insects (2075-4450), 2017, v. 8, n. 1, p. 2, doi. 10.3390/insects8010002

By:

Francis, Sheena A. M.;
Taylor-Wells, Jennina;
Gross, Aaron D.;
Bloomquist, Jeffrey R.

Publication type:

Article

Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy.

Published in:

Drug Delivery, 2020, v. 27, n. 1, p. 410, doi. 10.1080/10717544.2020.1731861

By:

Li, Tingting;
Wang, Ye;
Chen, Jiahao;
Gao, Xiaoshu;
Pan, Siqi;
Su, Yu;
Zhou, Xinrong

Publication type:

Article

Formulation Development and Evaluation of the Therapeutic Efficacy of Brinzolamide Containing Nanoemulsions.

Published in:

Iranian Journal of Pharmaceutical Research, 2017, v. 16, n. 3, p. 847

By:

Mahboobian, Mohammad Mehdi;
Seyfoddin, Ali;
Rupenthal, Ilva D.;
Aboofazeli, Reza;
Foroutan, Seyed Mohsen

Publication type:

Article

Safety news.

Published in:: WHO Drug Information, 2016, v. 30, n. 4, p. 577
Publication type:: Article

İnfantil Nistagmus Sendromunda Topikal Brinzolamid Kullanımının Göz İçi Basıncı Üzerine Etkisi.

Published in:

MN Opthalmology / MN Oftalmoloji, 2022, v. 29, n. 3, p. 154

By:

ÇELİK, Selcen;
PAŞAOĞLU, Işıl;
İNAL, Aslı;
OCAK, Osman Bulut;
GÜREZ, Ceren;
HÜSEYİNHAN, Zahid;
YILMAZ, Tolga;
GÖKYİĞİT, Birsen

Publication type:

Article

Development and application of RP--HPLC method for estimation and evaluation of stability of brinzolamide in ophthalmic formulation.

Published in:

Journal of Chemical Metrology, 2024, v. 18, n. 1, p. 1, doi. 10.25135/jcm.2311.2949

By:

Patel, Mehul;
Dwivedi, Ritu;
Shah, Umang;
Kachhiya, Heta

Publication type:

Article

Effect of topical brinzolamide on visual function and waveform in patients of infantile nystagmus syndrome: A randomized control trial.

Published in:

Indian Journal of Ophthalmology, 2024, v. 72, n. 7, p. 976, doi. 10.4103/IJO.IJO_1010_23

By:

Yadav, Bhupendra;
Saxena, Rohit;
Dhiman, Rebika;
Kochhar, Kanwal P.;
Patil, Ashlesh;
Sharma, Pradeep;
Sihota, Ramanjit;
Tandon, Radhika

Publication type:

Article

Effect of prophylactic intraocular pressure-lowering medication (brinzolamide) on intraocular pressure after ranibizumab intravitreal injection: A case-control study.

Published in:

2016

By:

Shuang Song;
Xiao-bing Yu;
Hong Dai;
Song, Shuang;
Yu, Xiao-Bing;
Dai, Hong

Publication type:

journal article

Brinzolamide/timolol versus dorzolamide/timolol fixed combinations: A hospital-based, prospective, randomized study.

Published in:

2016

By:

Galose, Mary S.;
Elsaied, Heba M.;
Macky, Tamer A.;
Fouad, Pakinam H.

Publication type:

journal article

Quantification of Carbonic Anhydrase Inhibitors and Metabolites in Urine and Hair of Patients and Their Relatives.

Published in:

Biology (2079-7737), 2022, v. 11, n. 10, p. N.PAG, doi. 10.3390/biology11101379

By:

Lo Faro, Alfredo Fabrizio;
Tini, Anastasio;
Bambagiotti, Giulia;
Pirani, Filippo;
Faragalli, Andrea;
Carle, Flavia;
Pacella, Elena;
Ceka, Artan;
Moretti, Marco;
Gottardi, Massimo;
Lassandro, Nicola Vito;
Nicolai, Michele;
Lupidi, Marco;
Mariotti, Cesare;
Busardò, Francesco Paolo;
Carlier, Jeremy

Publication type:

Article

Ocular and systemic pharmacokinetics of brimonidine and brinzolamide after topical administration in rabbits: comparison between fixed-combination and single-drug formulations.

Published in:

Current Eye Research, 2021, v. 46, n. 3, p. 380, doi. 10.1080/02713683.2020.1800046

By:

Suzuki, Gen;
Kunikane, Eriko;
Shigemi, Wakasa;
Shinno, Keisuke;
Kozai, Seiko;
Kurata, Masaaki;
Kawamura, Akio

Publication type:

Article

Efficacy and tolerability of brinzolamide/brimonidine suspension and prostaglandin analogs in patients previously treated with dorzolamide/timolol solution and prostaglandin analogs.

Published in:

Clinical Ophthalmology, 2016, v. 10, p. 583, doi. 10.2147/OPTH.S98607

By:

Lo, Jonathan S.;
Pang, Pierre M.;
Lo, Samuel C.

Publication type:

Article

Brinzolamide 1%/timolol versus dorzolamide 2%/ timolol in the treatment of open-angle glaucoma or ocular hypertension: prospective randomized patient-preference study.

Published in:

Clinical Ophthalmology, 2015, v. 9, p. 2263, doi. 10.2147/OPTH.S88891

By:

Altafini, Romeo;
Scherzer, Maria-Luise;
Hubatsch, Douglas A.;
Frezzotti, Paolo

Publication type:

Article

Clinical effectiveness of brinzolamide 1%--brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension.

Published in:

Clinical Ophthalmology, 2015, v. 9, p. 2201, doi. 10.2147/OPTH.S72380

By:

Sharma, Sourabh;
Trikha, Sameer;
Perera, Shamira A.;
Tin Aung

Publication type:

Article

Daily Costs and Cost Effectiveness of Glaucoma Fixed Combinations in China.

Published in:

Journal of Ophthalmology, 2020, p. 1, doi. 10.1155/2020/2406783

By:

Xu, Chenjia;
Guo, Ruru;
Huang, Dandan;
Ji, Jian;
Liu, Wei

Publication type:

Article

Co-delivery of Brinzolamide and Timolol from Micelles-laden Contact Lenses: In vitro and In Vivo Evaluation.

Published in:

Pharmaceutical Research, 2024, v. 41, n. 3, p. 531, doi. 10.1007/s11095-024-03672-8

By:

Yang, Hongyu;
Zhang, Faxing;
Fan, Yingzhen;
Zhang, Jian;
Fang, Ting;
Xing, Dandan;
Zhen, Yanli;
Nie, Zhihao;
Liu, Yaming;
Wang, Dongkai;
Li, Ji

Publication type:

Article

Ocular Pharmacokinetic Properties of Intravitreally Injected Aflibercept in Rabbits After Using Brinzolamide/Timolol Eye Drops.

Published in:

Journal of Ocular Pharmacology & Therapeutics, 2023, v. 39, n. 3, p. 229, doi. 10.1089/jop.2022.0146

By:

Zhou, Tianyang;
Li, Xiang;
Yang, Jingjing;
Xia, Huiyun;
Liu, Qian;
He, Jijun;
Zhang, Junjie

Publication type:

Article

Response to Chua et al. re: "The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study".

Published in:

2019

By:

Jin, Sang Wook

Publication type:

journal article

Re: "The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study" by Jin and Lee (J. Ocul. Pharmacol. Ther. 34:274-279, 2018).

Published in:

2019

By:

Chua, Paul Y.;
Clare, Gerry;
Leslie, Thorfinn

Publication type:

journal article

The 24-Hour Effects of Brinzolamide/Brimonidine Fixed Combination and Timolol on Intraocular Pressure and Ocular Perfusion Pressure.

Published in:

2017

By:

Seibold, Leonard K.;
DeWitt, Peter E.;
Kroehl, Miranda E.;
Kahook, Malik Y.

Publication type:

journal article

Evaluation of the effects on choroidal thickness of bimatoprost 0.03% versus a brinzolamide 1.0%/timolol maleate 0.5% fixed combination.

Published in:

Cutaneous & Ocular Toxicology, 2017, v. 36, n. 4, p. 397, doi. 10.1080/15569527.2017.1315128

By:

Akyol, Nurettin;
Kalkisim, Ahmet;
Turk, Adem;
Kola, Mehmet;
Imamoglu, Halil Ibrahim

Publication type:

Article

Identification of Possible Causative Agents in a Polymedicated Patient Presenting With Toxic Epidermal Necrolysis.

Published in:

Journal of Pharmacy Practice, 2021, v. 34, n. 6, p. 970, doi. 10.1177/0897190020934295

By:

Khazaka, Michael;
Laverdière, Jeanne;
Bouchard, Audrey;
Ferreira, Victor;
Mathieu, Alexandre

Publication type:

Article

Investigating the ocular toxicity potential and therapeutic efficiency of in situ gel nanoemulsion formulations of brinzolamide.

Published in:

Toxicology Research, 2020, v. 9, n. 4, p. 578, doi. 10.1093/toxres/tfaa066

By:

Talaei, Sima;
Mahboobian, Mohammad Mehdi;
Mohammadi, Mojdeh

Publication type:

Article

A Simple Validated LC-UV Method for the Simultaneous Determination of Brimonidine and Brinzolamide in the Presence of Brinzolamide's Degradation Product (Major Metabolite) in Rabbit Aqueous Humor.

Published in:

Journal of Chromatographic Science, 2025, v. 63, n. 2, p. 1, doi. 10.1093/chromsci/bmae040

By:

Mubarak, Marwa A Wahab;
Mohammad, M Abdul-Azim;
El-Bagary, Ramzia I;
Elkady, Ehab;
Abo-Talib, Nisreen F

Publication type:

Article

Ocular microemulsion of brinzolamide: Formulation, physicochemical characterization, and in vitro irritation studies based on EpiOcular™ eye irritation assay.

Published in:

Pharmaceutical Development & Technology, 2021, v. 26, n. 7, p. 765, doi. 10.1080/10837450.2021.1944206

By:

Siafaka, Panoraia I.;
Çağlar, Emre Şefik;
Sipahi, Hande;
Charehsaz, Mohammad;
Aydın, Ahmet;
Üstündağ Okur, Neslihan

Publication type:

Article

Ocular Distribution of Brimonidine and Brinzolamide after Topical Instillation of a 0.1% Brimonidine Tartrate and 1% Brinzolamide Fixed-Combination Ophthalmic Suspension: An Interventional Study.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 13, p. 4175, doi. 10.3390/jcm12134175

By:

Orii, Yusuke;
Kunikane, Eriko;
Yamada, Yutaka;
Morioka, Masakazu;
Iwasaki, Kentaro;
Arimura, Shogo;
Mizuno, Akemi;
Inatani, Masaru

Publication type:

Article

The Efficacy, Safety and Satisfaction Associated with Switching from Brinzolamide 1% and Brimonidine 0.1% to a Fixed Combination of Brinzolamide 1% and Brimonidine 0.1% in Glaucoma Patients.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 22, p. 5228, doi. 10.3390/jcm10225228

By:

Onoe, Hiromitsu;
Hirooka, Kazuyuki;
Nagayama, Mikio;
Hirota, Atsushi;
Mochizuki, Hideki;
Sagara, Takeshi;
Suzuki, Katsuyoshi;
Okumichi, Hideaki;
Kiuchi, Yoshiaki

Publication type:

Article

Concurrent Uveal and Vitreoretinal Lymphoma Masquerading as Anterior Uveitis.

Published in:

2016

By:

Bell, James;
Harrison, Jonathan;
Mamalis, Nick;
Floyd, Anne;
Shakoor, Akbar;
Ambati, Balamurali

Publication type:

Case Study

A comparative study on efficacy of fixed combination timolol/brinzolamide versus travoprost monotherapy in drug-naïve open-angle glaucoma patients.

Published in:

Therapeutic Advances in Ophthalmology, 2020, v. 12, p. 1, doi. 10.1177/2515841420909666

By:

Dixit, Alok;
Ashish, Atul;
Sharma, Reena

Publication type:

Article

Sulfonamide inhibition studies of two β-carbonic anhydrases from the ascomycete fungus Sordaria macrospora, CAS1 and CAS2.

Published in:

Journal of Enzyme Inhibition & Medicinal Chemistry, 2018, v. 33, n. 1, p. 390, doi. 10.1080/14756366.2018.1425687

By:

Vullo, Daniela;
Lehneck, Ronny;
Pöggeler, Stefanie;
Supuran, Claudiu T.

Publication type:

Article

Evaluation of the Use of Brinzolamide-Brimonidine Fixed Combination in Maximum Medical Therapy.

Published in:

Turkish Journal of Ophthalmology / Turk Oftalmoloji Dergisi, 2022, v. 52, n. 4, p. 262, doi. 10.4274/tjo.galenos.2021.25488

By:

Tekeli, Oya;
Köse, Helin Ceren

Publication type:

Article

Efficacy of Topical Brinzolamide Treatment in Posterior Microphthalmos-Related Macular Cystoid Lesions: A Case Series.

Published in:

Turkish Journal of Ophthalmology / Turk Oftalmoloji Dergisi, 2020, v. 50, n. 1, p. 44, doi. 10.4274/tjo.galenos.2019.40504

By:

Engin, Ceren Durmaz;
Ekinci, Umut Baran;
Selver, Alper;
Saatçi, Ali Osman

Publication type:

Article

Additive Intraocular Pressure-Lowering Effects of Ripasudil with Glaucoma Therapeutic Agents in Rabbits and Monkeys.

Published in:

Journal of Ophthalmology, 2017, p. 1, doi. 10.1155/2017/7079645

By:

Kaneko, Yoshio;
Ohta, Masayuki;
Isobe, Tomoyuki;
Nakamura, Yuto;
Mizuno, Ken

Publication type:

Article

Efficacy and safety assessment of preservative‐free latanoprost (T2345) versus Xalatan™ in ocular hypertensive or glaucomatous patients.

Published in:: Acta Ophthalmologica (1755375X), 2012, v. 90, p. 0, doi. 10.1111/j.1755-3768.2012.F030.x
Publication type:: Article

Prevention of ocular hypertension in patients receiving intra‐vitreal steroids.

Published in:

Acta Ophthalmologica (1755375X), 2012, v. 90, p. 0, doi. 10.1111/j.1755-3768.2012.4613.x

By:

RADOI, C;
AFRIAT, M;
DUCASSE, A;
ARNDT, C

Publication type:

Article

Effects of Topical Carbonic Anhydrase Inhibitors on the Olfactory Sense.

Published in:

Beyoglu Eye Journal, 2021, v. 6, n. 1, p. 19, doi. 10.14744/bej.2021.27676

By:

Gul, Fatih Cem;
Guler, Mete;
Kobat, Sabiha Gungor;
Duzer, Sertac;
Sakallioglu, Oner;
Celik, Fatih;
Akyigit, Abdulvahap

Publication type:

Article